Rubric Capital Management (New York)’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-356,100
| Closed | -$3.61M | – | 102 |
|
|
2022
Q3 | $3.61M | Buy |
+356,100
| New | +$3.61M | 0.18% | 70 |
|
|
2020
Q4 | – | Sell |
-550,747
| Closed | -$8.14M | – | 80 |
|
|
2020
Q3 | $8.14M | Sell |
550,747
-395,710
| -42% | -$5.85M | 0.76% | 44 |
|
|
2020
Q2 | $19.9M | Buy |
946,457
+72,880
| +8% | +$1.53M | 2.29% | 19 |
|
|
2020
Q1 | $20.2M | Buy |
873,577
+700,177
| +404% | +$16.2M | 3.19% | 14 |
|
|
2019
Q4 | $4.49M | Buy |
+173,400
| New | +$4.49M | 0.51% | 38 |
|